# Merck KGaA

科技公司——MilliporeSigma/Mobius一次性生物加工系统、生化试剂和生物制药过程生命周期管理工具；营收225亿欧元；总部达姆施塔特。

Source: https://cn.bioecon.ru/companies/merck-kgaa/
Updated: 2026-06-19

- 国家: Germany
- 营收: €22B
- 员工: ~63,000 emp

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 营收 | €211.02亿（FY2025） | https://ir-api.eqs.com/storage/ir/9fc60a/documents/d6bc9038-21a5-43f7-b217-1978b9ef0ef3/DE0006599905-JA-2025-EQ-E-00.pdf, https://www.reports.emdgroup.com/en/annualreport/2025/_assets/downloads/entire-emd-ar25.pdf |
| 员工人数 | 全球62,461名员工（截至2025年12月31日） | https://ir-api.eqs.com/storage/ir/9fc60a/documents/d6bc9038-21a5-43f7-b217-1978b9ef0ef3/DE0006599905-JA-2025-EQ-E-00.pdf, https://www.reports.emdgroup.com/en/annualreport/2025/_assets/downloads/entire-emd-ar25.pdf |
| 生产基地 | 全球55个以上生产与检测基地，包括德国达姆施塔特、法国Molsheim、美国马萨诸塞州Danvers、中国无锡、韩国大田及爱尔兰Blarney的设施。 | https://megaproject.com/news/factory/milliporesigma-opens-29m-biologics-testing-facility-in-germany, https://storage.mtender.gov.md/get/34f7a052-5ac4-457b-8b1d-956fe6b0d2a4-1668157815588, https://www.businesswire.com/news/home/20240320070934/en/MilliporeSigma-Invests-More-than-%E2%82%AC-300-Million-in-New-Life-Science-Production-Site-in-Korea, https://www.merckmillipore.com/CH/en/20150908_205416, https://www.sigmaaldrich.com/US/en/collections/press/investment-to-strengthen-manufacturing-capabilities-in-molsheim-france |
| 产能 | 通过多项多年期投资实现显著扩张，包括爱尔兰€1.5亿的过滤器生产设施、韩国超过€3亿的生物工艺中心、Molsheim的€1.3亿扩建，以及达姆施塔特€2500万/€2900万的BioReliance检测设施。 | https://ir-api.eqs.com/storage/ir/9fc60a/documents/d6bc9038-21a5-43f7-b217-1978b9ef0ef3/DE0006599905-JA-2025-EQ-E-00.pdf, https://megaproject.com/news/factory/milliporesigma-opens-29m-biologics-testing-facility-in-germany, https://www.businesswire.com/news/home/20240320070934/en/MilliporeSigma-Invests-More-than-%E2%82%AC-300-Million-in-New-Life-Science-Production-Site-in-Korea, https://www.reports.emdgroup.com/en/annualreport/2025/_assets/downloads/entire-emd-ar25.pdf, https://www.sigmaaldrich.com/US/en/collections/press/investment-to-strengthen-manufacturing-capabilities-in-molsheim-france |
| 认证 | ISO 9001、ISO 14001、ISO 50001、ISO 27001、ISO 45001、ISO 13485、ISO 17025、ISO 17034、FSSC 22000及Excipact GMP/GDP认证。 | https://www.dqsglobal.com/en/customer-database/merck-kgaa, https://www.excipact.org/certificate-holder-search-results/group_title/Merck.html, https://www.reports.merckgroup.com/en/sustainability-report/2021/_assets/downloads/entire-merck-sr21.pdf, https://www.sigmaaldrich.com/US/en/life-science/quality-and-regulatory-management/iso-certificates |
| 监管批准 | 维持多项区域监管与质量合规标准，包括美国FDA、EU-GMP、日本PMDA、英国MHRA、WHO-GMP及其他针对原料药与药用成分的区域认证。 [中等置信度] | https://chemxpert.com/download-summary-company?value=E+Merck+Kgaa, https://www.merckmillipore.com/INTL/en/20130717_154754 |

独立来源: businesswire.com, chemxpert.com, dqsglobal.com, excipact.org, ir-api.eqs.com, megaproject.com, merckmillipore.com, reports.emdgroup.com, reports.merckgroup.com, sigmaaldrich.com, storage.mtender.gov.md

## 技术

- [一次性生物工艺与模块化工厂](https://cn.bioecon.ru/technology/single-use-bioprocessing/)
- [一次性生物工艺系统](https://cn.bioecon.ru/technology/single-use-assemblies/)
- [一次性袋式生物反应器（50L-2000L）](https://cn.bioecon.ru/technology/single-use-bag-bioreactors-50l-2000l/)
- [培养基制造（B2B 生产设备）](https://cn.bioecon.ru/technology/media-manufacturing-equipment/)
- [无菌检测系统](https://cn.bioecon.ru/technology/sterility-testing-systems/)
- [水纯化与实验室用水系统](https://cn.bioecon.ru/technology/water-systems/)
- [细胞培养基（B2B耗材）](https://cn.bioecon.ru/technology/cell-culture-media-b2b/)